Treatment strategies for co-occurring ADHD and substance use disorders.

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry (2010) 2.53

Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial. J Dual Diagn (2009) 0.92

Childhood ADHD and risk for substance dependence in adulthood: a longitudinal, population-based study. PLoS One (2014) 0.82

Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin (2011) 0.81

An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders. J ADHD Relat Disord (2010) 0.77

Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review. J Atten Disord (2015) 0.75

Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage. Eur J Drug Metab Pharmacokinet (2017) 0.75

Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol. Child Fam Behav Ther (2014) 0.75

Male adolescent substance use disorder and attention-deficit hyperactivity disorder: a review of the literature. ISRN Addict (2012) 0.75

Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us? Harv Rev Psychiatry (2017) 0.75

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 45.33

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA (1990) 17.70

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry (2004) 15.99

The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry (2005) 12.53

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85

Limitations of the application of fourfold table analysis to hospital data. Biometrics (1946) 5.44

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry (2000) 4.34

The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol (2002) 4.30

Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol (2003) 3.86

A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology (2005) 3.53

Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry (2003) 3.10

Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry (1999) 2.95

Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry (2005) 2.87

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics (2003) 2.79

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry (2006) 2.78

Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend (1995) 2.76

Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol (2001) 2.71

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry (2003) 2.66

Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2005) 2.66

Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet (1995) 2.54

How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med (2002) 2.51

Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry (1997) 2.49

Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry (1996) 2.49

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci (2001) 2.41

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am (2004) 2.39

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2004) 2.36

Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry (2000) 2.26

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res (1998) 2.21

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 2.21

Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am (2000) 2.18

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther (2005) 2.08

Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics (2005) 1.95

Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry (2006) 1.87

Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology (2004) 1.84

The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med (2005) 1.83

Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J Neurophysiol (1996) 1.55

Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry (2004) 1.53

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol (2004) 1.49

Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ (2003) 1.47

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.43

A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder. Aust N Z J Psychiatry (2002) 1.43

Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat (2001) 1.42

Psychotherapy of attention deficit hyperactivity disorder in adults--a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci (2002) 1.42

Brain imaging of attention deficit/hyperactivity disorder. Ann N Y Acad Sci (2001) 1.42

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend (2006) 1.42

Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry (2000) 1.42

Methamphetamine self-administration by humans. Psychopharmacology (Berl) (2001) 1.40

Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol (1998) 1.35

Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol (2002) 1.35

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1999) 1.35

Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction (2003) 1.32

Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics (2006) 1.29

Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend (1998) 1.25

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry (2005) 1.25

Stimulant medications. J Am Acad Child Adolesc Psychiatry (1999) 1.25

Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry (2002) 1.24

Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry (1996) 1.24

Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry (2004) 1.22

History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry (1993) 1.22

Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. J Clin Psychopharmacol (2001) 1.19

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend (2005) 1.18

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry (2001) 1.16

Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. Am J Addict (2004) 1.16

Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict (1998) 1.14

Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol (2004) 1.12

Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol (1997) 1.11

Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse (1999) 1.10

Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Subst Abus (2004) 1.03

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2001) 1.03

Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry (2006) 1.02

Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav (2004) 1.02

Contribution of ADHD symptoms to substance problems and delinquency in conduct-disordered adolescents. J Abnorm Child Psychol (1996) 1.00

Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction (2001) 0.99

Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction (2000) 0.99

A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD. J Am Acad Child Adolesc Psychiatry (2003) 0.98

Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr Clin North Am (1999) 0.96

Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of Novelty Seeking. Mol Psychiatry (1998) 0.96

Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis (2002) 0.95

Assessing methylphenidate preference in ADHD patients using a choice procedure. Psychopharmacology (Berl) (2004) 0.93

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry (2006) 0.93

Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry (1989) 0.93

Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry (1998) 0.92

Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol (2000) 0.92

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry (1998) 0.92

Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. J Clin Psychiatry (2005) 0.91

A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 0.91

An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J Addict Dis (2004) 0.86

Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence. J Addict Dis (2004) 0.86

Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment. J Clin Psychopharmacol (2000) 0.83

The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology. Adv Pediatr (1992) 0.82

Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices. J Am Acad Child Adolesc Psychiatry (2004) 0.81

An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol (1996) 0.80

Diagnosing mental disorders in office-based pediatric practice. J Dev Behav Pediatr (1992) 0.80

Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatr Serv (2000) 0.80

Predicting substance abuse in juvenile offenders: attention deficit disorder versus aggressivity. Child Psychiatry Hum Dev (1990) 0.77

Assessment of symptoms of attention-deficit hyperactivity disorder in adults with substance use disorders. Psychiatr Serv (1997) 0.77

Attempted abuse of concerta. J Am Acad Child Adolesc Psychiatry (2002) 0.76

Venlafaxine in children and adolescents with attention deficit hyperactivity disorder. Psychiatry Clin Neurosci (2004) 0.75

Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA (2004) 4.12

Treatment of cannabis use disorders: a review of the literature. Am J Addict (2007) 1.48

Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39

A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict (2009) 1.35

A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend (2005) 1.31

Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry (2012) 1.18

Treatment of depression in patients with opiate dependence. Biol Psychiatry (2004) 1.16

Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15

Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am (2012) 1.12

A pilot double-blind treatment trial of memantine for alcohol dependence. Alcohol Clin Exp Res (2007) 1.11

Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr Res (2013) 1.10

Mindfulness impairments in individuals seeking treatment for substance use disorders. Am J Drug Alcohol Abuse (2011) 1.10

Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend (2005) 1.08

Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Horm Behav (2008) 1.06

Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug Alcohol Depend (2005) 1.06

Training physicians to treat substance use disorders. Curr Psychiatry Rep (2008) 1.06

The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders. Harv Rev Psychiatry (2009) 1.05

Adult ADHD and substance abuse: diagnostic and treatment issues. Subst Use Misuse (2005) 1.04

Evaluation of a combined online and in person training in the use of buprenorphine. Subst Abus (2006) 1.04

Uses of coercion in addiction treatment: clinical aspects. Am J Addict (2008) 1.04

Alcohol increases impulsivity and abuse liability in heavy drinking women. Exp Clin Psychopharmacol (2012) 1.02

A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug Alcohol Depend (2010) 1.01

Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction (2012) 1.00

Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients. J Opioid Manag (2011) 0.98

Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol (2005) 0.97

Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement. Drug Alcohol Depend (2012) 0.94

Response to alcohol in females with a paternal history of alcoholism. Psychopharmacology (Berl) (2003) 0.94

Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction (2013) 0.92

Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl) (2011) 0.92

Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? Drug Alcohol Depend (2013) 0.92

A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. Drug Alcohol Depend (2011) 0.92

Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial. Addict Behav (2010) 0.89

Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations. Psychiatr Ann (2008) 0.89

The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res (2013) 0.89

Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response. J Clin Psychiatry (2013) 0.88

Treating depression in substance abusers. Curr Psychiatry Rep (2006) 0.87

Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome. Am J Drug Alcohol Abuse (2006) 0.87

Response to alcohol in women: role of the menstrual cycle and a family history of alcoholism. Drug Alcohol Depend (2011) 0.87

The effects of progesterone pretreatment on the response to oral d-amphetamine in Women. Horm Behav (2010) 0.86

Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend (2013) 0.86

Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. Am J Addict (2007) 0.85

Pediatric obesity: parallels with addiction and treatment recommendations. Harv Rev Psychiatry (2008) 0.85

Predictors of treatment contact among individuals with cannabis dependence. Am J Drug Alcohol Abuse (2004) 0.85

Predictors of cannabis dependence recovery among epidemiological survey respondents in the United States. Am J Drug Alcohol Abuse (2007) 0.84

Antiretroviral medication: an emerging category of prescription drug misuse. Am J Addict (2013) 0.84

Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts? J Affect Disord (2011) 0.83

A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence. J Addict Dis (2010) 0.83

Early abstinence in cocaine dependence: influence of comorbid major depression. Am J Addict (2007) 0.83

Screening and intervention for alcohol and illicit drug abuse:a survey of internal medicine housestaff. J Addict Dis (2005) 0.83

A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict (2011) 0.82

Smoking and psychopathology increasingly associated in recent birth cohorts. Drug Alcohol Depend (2013) 0.82

Socially sanctioned coercion mechanisms for addiction treatment. Am J Addict (2007) 0.81

Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence. J Addict Dis (2006) 0.81

Pharmacotherapy for alcohol-related disorders: what clinicians should know. Harv Rev Psychiatry (2005) 0.81

The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict (2013) 0.81

Improving temporal efficiency of outpatient buprenorphine induction. Am J Addict (2011) 0.80

Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review. Am J Drug Alcohol Abuse (2008) 0.80

The interface between substance abuse and chronic pain management in primary care: a curriculum for medical residents. Subst Abus (2009) 0.80

Does remission from alcohol and drug use disorders increase the likelihood of smoking cessation among nicotine dependent young adults? Soc Psychiatry Psychiatr Epidemiol (2008) 0.80

The effects of alcohol and drug dependence on the course of depression. Am J Addict (2006) 0.79

Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use. Am J Addict (2008) 0.79

Substance abuse among patients with schizophrenia. J Psychiatr Pract (2002) 0.78

The "younger-sibling-at-risk design": a pilot study of adolescents with ADHD and an older sibling with substance use disorder. Am J Drug Alcohol Abuse (2011) 0.78

Quetiapine treatment of zolpidem dependence. Am J Addict (2007) 0.78

Comparison of substance use milestones in cannabis- and cocaine-dependent patients. J Addict Dis (2012) 0.78

Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants. J Subst Abuse Treat (2011) 0.78

Specificity of verbal learning impairment and recovery in a marijuana-dependent male: the effects of sustained marijuana abstinence. Cogn Neuropsychiatry (2011) 0.77

Open-label pilot study of quetiapine treatment for cannabis dependence. Am J Drug Alcohol Abuse (2014) 0.77

Verbal learning in marijuana users seeking treatment: a comparison between depressed and non-depressed samples. Am J Drug Alcohol Abuse (2014) 0.77

Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. Eur Addict Res (2015) 0.77

Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders. J Addict Med (2013) 0.76

Antisocial behavioral syndromes in cocaine and cannabis dependence. Am J Drug Alcohol Abuse (2008) 0.76

One-year follow-up study of suicide attempters treated for drug dependence. Am J Addict (2006) 0.76

First treatment contact for ADHD: predictors of and gender differences in treatment seeking. Psychiatr Serv (2014) 0.76

Effects of research setting on observed depressive symptoms in marijuana users. J Subst Abuse Treat (2009) 0.75

Individual mindfulness-based psychotherapy for cannabis or cocaine dependence: a pilot feasibility trial. Am J Addict (2013) 0.75

Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers. Am J Addict (2015) 0.75

Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us? Harv Rev Psychiatry (2017) 0.75

Verbal abilities as predictors of retention among adolescents in a therapeutic community. Child Psychiatry Hum Dev (2006) 0.75